SET domain containing protein 1A (SETD1A) is a protein that serves as a component of a
histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated
histone H3 at the lys4 residue (
K4). SETD1A is highly homologous with
SETDB1 but has a distinct subnuclear distribution.[1]
According to a review published in 2018, mutations of the SETD1A gene may increase the risk of
schizophrenia, based on studies available up to that date.[4]
History
The protein was first described in human in 2003 by Wysocka et al.
^Kummeling J, Stremmelaar DE, Raun N, Reijnders MR, Willemsen MH, Ruiterkamp-Versteeg M, Schepens M, Man CC, Gilissen C, Cho MT, McWalter K, Sinnema M, Wheless JW, Simon ME, Genetti CA, Casey AM, Terhal PA, van der Smagt JJ, van Gassen KL, Joset P, Bahr A, Steindl K, Rauch A, Keller E, Raas-Rothschild A, Koolen DA, Agrawal PB, Hoffman TL, Powell-Hamilton NN, Thiffault I, Engleman K, Zhou D, Bodamer O, Hoefele J, Riedhammer KM, Schwaibold EM, Tasic V, Schubert D, Top D, Pfundt R, Higgs MR, Kramer JM, Kleefstra T (June 2021).
"Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome"(PDF). Molecular Psychiatry. 26 (6): 2013–2024.
doi:
10.1038/s41380-020-0725-5.
PMID32346159.
S2CID212792900.